Heart Failure with Sunitinib;Prolonged QT Interval,Syncope,and Delirium with Galantamine;Memantine-Induced Hepatitis;Cabergoline-Associated Erythema Nodosum;“Sleep Driving” and the Use of Nonbenzodiazepine Hypnotics;Atypical Fractures in Postmenopausal Women Taking Alendronate;Drug-Related Problems in Patients with Human Immunodeficiency Virus

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the Food and Drug Administration's (FDA) medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.